
H G Pars Pharmaceutical Labs Inc (AKA: Sisa Pharmaceuticals) Profile last edited on: 6/4/14
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
9 Hancock Street
Lexington, MA 02420
Lexington, MA 02420
(781) 863-8390 |
N/A |
N/A |
Location: Single
Congr. District: 05
County: Middlesex
Congr. District: 05
County: Middlesex
Public Profile
Originally doing business as Sisa Pharmaceuticals in Cambridge, MA, the firm was an awardee in the original NSF and DOD programs (called DESAT) which formed the basis on which the federal SBIR program was initiated. Harry Pars, founding president, had previously worked at Arthur D Little. He was actively involved in the projects out SBANE - Smaller Business Assoiation of New England - which launched the initaive to make SBIR government wide. He used a familial connection to the then Speaker of the house - Tip O'Neil - to get the enabling legislation onto the floor of the House where it had been stalled by the energetic opposition through a process of sequential referrals in seven House Committees. The Senate had already approved the program by an almost unanimous vote. After the Speaker's order to release the bill, the highly conscientious debate in the House lasted several hours and involved several votes - the first of which passed by the narrowest of margins. The tide then turned and each vote was more in favor than the last with many Members subsequently chnaging their vote when passage of the law was eventually assured.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
1985 | 1 | NIH | $45,000 | |
Project Title: Water-Soluble Derivatives of Gossypol | ||||
1985 | 2 | NIH | $623,455 | |
Project Title: Benzopyranopyridines as novel analagesic agents | ||||
1985 | 1 | NIH | $50,000 | |
Project Title: New-B Lactam antibiotics: Oxacephalosporin analogs | ||||
1985 | 1 | NIH | $50,000 | |
Project Title: Bacteriocides & fungicides for health care | ||||
1985 | 1 | NIH | $50,000 | |
Project Title: Cannabinoids as antihypertensive agents |
Key People / Management
Harry G Pars -- President
Paul Blundell
Paul Blundell
Eric Duffy
Ellen M Essigmann
Paul Meltzer
Paul Blundell
Paul Blundell
Eric Duffy
Ellen M Essigmann
Paul Meltzer
Company News
There are no news available.